Tilray Brands (TLRY) Competitors $0.57 -0.01 (-2.10%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.57 +0.00 (+0.23%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLRY vs. ACB, CGC, CRON, OGI, SNDL, RXRX, APLS, XENE, IBRX, and ARWRShould you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Recursion Pharmaceuticals (RXRX), Apellis Pharmaceuticals (APLS), Xenon Pharmaceuticals (XENE), ImmunityBio (IBRX), and Arrowhead Pharmaceuticals (ARWR). These companies are all part of the "pharmaceutical products" industry. Tilray Brands vs. Its Competitors Aurora Cannabis Canopy Growth Cronos Group Organigram Global SNDL Recursion Pharmaceuticals Apellis Pharmaceuticals Xenon Pharmaceuticals ImmunityBio Arrowhead Pharmaceuticals Aurora Cannabis (NASDAQ:ACB) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations. Which has more risk and volatility, ACB or TLRY? Aurora Cannabis has a beta of 1.84, suggesting that its stock price is 84% more volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500. Which has better valuation & earnings, ACB or TLRY? Aurora Cannabis has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$246.72M1.02$1.63M$0.1140.73Tilray Brands$821.31M0.70-$244.98M-$2.31-0.25 Does the media refer more to ACB or TLRY? In the previous week, Tilray Brands had 40 more articles in the media than Aurora Cannabis. MarketBeat recorded 42 mentions for Tilray Brands and 2 mentions for Aurora Cannabis. Tilray Brands' average media sentiment score of 0.68 beat Aurora Cannabis' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tilray Brands 12 Very Positive mention(s) 6 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 4 Very Negative mention(s) Positive Do analysts prefer ACB or TLRY? Tilray Brands has a consensus target price of $1.92, indicating a potential upside of 237.03%. Given Tilray Brands' higher possible upside, analysts plainly believe Tilray Brands is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67Tilray Brands 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Do insiders & institutionals believe in ACB or TLRY? 47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 9.4% of Tilray Brands shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 0.6% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is ACB or TLRY more profitable? Aurora Cannabis has a net margin of 1.32% compared to Tilray Brands' net margin of -265.69%. Aurora Cannabis' return on equity of 0.13% beat Tilray Brands' return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis1.32% 0.13% 0.10% Tilray Brands -265.69%-6.83%-5.45% SummaryAurora Cannabis beats Tilray Brands on 10 of the 16 factors compared between the two stocks. Get Tilray Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLRY vs. The Competition Export to ExcelMetricTilray BrandsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$584.67M$10.40B$5.48B$9.53BDividend YieldN/A1.99%4.73%4.09%P/E Ratio-0.2518.4228.8623.83Price / Sales0.7029.01371.4466.13Price / Cash3.8122.3135.4557.96Price / Book0.383.478.265.54Net Income-$244.98M$234.77M$3.25B$259.28M7 Day Performance-17.40%-4.82%-3.73%-4.67%1 Month Performance17.21%1.80%4.28%4.38%1 Year Performance-69.42%-12.51%25.85%17.90% Tilray Brands Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLRYTilray Brands3.0467 of 5 stars$0.57-2.1%$1.92+237.0%-71.4%$584.67M$821.31M-0.252,650Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionGap DownACBAurora Cannabis0.3706 of 5 stars$4.52-5.5%N/A-26.0%$253.41M$246.72M40.951,130Upcoming EarningsCGCCanopy Growth0.4657 of 5 stars$1.02-6.9%N/A-84.5%$208.22M$269.00M-0.253,150News CoverageUpcoming EarningsCRONCronos Group2.5855 of 5 stars$2.02-2.2%N/A-17.0%$777.15M$117.61M15.50450News CoverageUpcoming EarningsOGIOrganigram Global1.4692 of 5 stars$1.43-3.7%N/A-15.3%$190.86M$117.47M14.25860News CoverageSNDLSNDL2.626 of 5 stars$1.47-2.3%$4.00+173.0%-25.3%$384.97M$927.61M-5.052,516Trending NewsEarnings ReportAnalyst RevisionRXRXRecursion Pharmaceuticals1.5269 of 5 stars$5.97-5.5%$7.00+17.4%-22.6%$2.42B$58.84M-3.36400Upcoming EarningsGap DownAPLSApellis Pharmaceuticals4.6994 of 5 stars$18.93+1.0%$40.00+111.3%-36.3%$2.37B$781.37M-10.56770Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionXENEXenon Pharmaceuticals2.9517 of 5 stars$30.84-0.4%$54.82+77.8%-30.3%$2.37B$9.43M-9.55210News CoveragePositive NewsShort Interest ↑IBRXImmunityBio2.2314 of 5 stars$2.57-3.2%$12.25+377.6%-50.5%$2.26B$14.74M-4.42590News CoverageGap DownARWRArrowhead Pharmaceuticals3.8257 of 5 stars$15.98-1.3%$43.71+173.5%-42.0%$2.21B$3.55M-11.41400News CoverageUpcoming Earnings Related Companies and Tools Related Companies ACB Competitors CGC Competitors CRON Competitors OGI Competitors SNDL Competitors RXRX Competitors APLS Competitors XENE Competitors IBRX Competitors ARWR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLRY) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tilray Brands, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tilray Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLRY Stock Alerts